Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 55224 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 57229 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 89482 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 92329 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 109160 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 112773 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 124613 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 135817 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 140259 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 142385 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 159565 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 183117 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | 197365 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | NICOTINAMIDE (M+H)+ | Peak area normalized | female | diabetic | no neuropathy |